Pre-injury polypharmacy predicts mortality in isolated severe traumatic brain injury patients
Document Type
Article
Publication Date
1-1-2017
Publication Title
American Journal of Surgery
Volume
213
Issue
6
First page number:
1104
Last page number:
1108
Abstract
Background The use of 5 or more medications is defined as polypharmacy (PPM). The clinical impact of PPM on the isolated severe traumatic brain injury (TBI) patient has not been defined. Methods A retrospective cohort study was performed at our academic level 1 trauma center examining patients with isolated TBI. Pre-injury medications were reviewed, and inhospital mortality was the primary measured outcome. Results There were 698 patients with an isolated TBI over the 5-year study period; 177 (25.4%) patients reported pre-injury PPM. There were 18 (10.2%) deaths in the PPM cohort and 24 (4.6%) deaths in the non-PPM cohort (P < .0001). Stepwise logistic regression analysis revealed a 2.3 times greater risk of mortality in the PPM patients (P =.019). Conclusions Pre-injury PPM increases mortality in patients with isolated severe TBI. This knowledge may provide opportunities for intervention in this population. © 2016 Elsevier Inc.
Disciplines
English Language and Literature
File Format
File Size
193 kb
Language
english
Repository Citation
Catapano, J. S.,
Chapman, A. J.,
Horner, L. P.,
Lu, M.,
Fraser, D. R.,
Fildes, J. J.
(2017).
Pre-injury polypharmacy predicts mortality in isolated severe traumatic brain injury patients.
American Journal of Surgery, 213(6),
1104-1108.
http://dx.doi.org/10.1016/j.amjsurg.2016.07.010